These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 29408534)
1. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. El Lakis M; Nockel P; Gaitanidis A; Guan B; Agarwal S; Welch J; Simonds WF; Weinstein L; Marx S; Nilubol N; Patel D; Merkel R; Tirosh A; Kebebew E J Am Coll Surg; 2018 May; 226(5):933-938. PubMed ID: 29408534 [TBL] [Abstract][Full Text] [Related]
2. The Role of Demographic and Clinical Factors in Germline Mutation Testing for Patients with Primary Hyperparathyroidism. Hangge PT; Dream S; Yen TWF; Doffek K; Stachowiak SM; Shaker J; Evans DB; Wang TS Ann Surg Oncol; 2024 Jun; 31(6):3964-3971. PubMed ID: 38459417 [TBL] [Abstract][Full Text] [Related]
3. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism. van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582 [TBL] [Abstract][Full Text] [Related]
4. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Starker LF; Akerström T; Long WD; Delgado-Verdugo A; Donovan P; Udelsman R; Lifton RP; Carling T Horm Cancer; 2012 Apr; 3(1-2):44-51. PubMed ID: 22187299 [TBL] [Abstract][Full Text] [Related]
5. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia. Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341 [TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study. Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924 [TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition. Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519 [TBL] [Abstract][Full Text] [Related]
8. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing. Park HS; Lee YH; Hong N; Won D; Rhee Y Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626 [TBL] [Abstract][Full Text] [Related]
9. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure. El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations. Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194 [TBL] [Abstract][Full Text] [Related]
11. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism? Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas. Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640 [TBL] [Abstract][Full Text] [Related]
14. HRPT2- (CDC73) RELATED HEREDITARY HYPERPARATHYROIDISM: A CASE SERIES FROM WESTERN INDIA. Khadilkar KS; Budyal SR; Kasliwal R; Lila AR; Bandgar T; Shah NS Endocr Pract; 2015 Sep; 21(9):1010-6. PubMed ID: 26121439 [TBL] [Abstract][Full Text] [Related]
15. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism. Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908 [TBL] [Abstract][Full Text] [Related]
16. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue. Marx SJ; Lourenço DM Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674 [TBL] [Abstract][Full Text] [Related]
17. Primary Hyperparathyroidism in Young Adult Patients. Gasior J; Kelz RR; Karakousis GC; Fraker DL; Wachtel H Ann Surg Oncol; 2023 Jul; 30(7):4156-4164. PubMed ID: 36930370 [TBL] [Abstract][Full Text] [Related]